Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of ß-thalassemia intermedia and major.

Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of ß-thalassemia intermedia and major. Haematologica. 2017 Nov 02;: Authors: Casu C, Lo Presti V, Oikonomidou PR, Melchiori L, Abdulmalik O, Ramos P, Rivella S PMID: 29097498 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29097498?dopt=Abstract

Source: Haematologica - November 2, 2017 Category: Hematology Authors: Casu C, Lo Presti V, Oikonomidou PR, Melchiori L, Abdulmalik O, Ramos P, Rivella S Tags: Haematologica Source Type: research

More News: